A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus

The recombinant vaccine, tgAAC09, based on an adeno-associated virus serotype 2 (AAV2) vector encoding HIV-1 subtype C Gag, protease, and part of reverse transcriptase, induced robust T cell and antibody responses in nonhuman primates. In a previous phase I study in 80 healthy HIV-seronegative Europ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS research and human retroviruses 2010-08, Vol.26 (8), p.933-942
Hauptverfasser: VARDAS, Eftyhia, KALEEBU, Pontiano, COX, Josephine, LEHRMAN, Jennifer, STEVENS, Gwynn, GILMOUR, Jill, TARRAGONA, Tony, HAYES, Peter, LOWENBEIN, Sarah, KIZITO, Eva, FAST, Patricia, HEALD, Alison E, BEKKER, Linda-Gail, SCHMIDT, Claudia, HOOSEN, Anwar, CHOMBA, Elwyn, JOHNSON, Philip R, ANKLESARIA, Pervin, BIRUNGI, Josephine, BARING, Burc, BOAZ, Mark
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!